Charles River Laboratories International (CRL) Accounts Payables (2009 - 2025)

Charles River Laboratories International's Accounts Payables history runs 17 years deep, the most recent figure standing at $148.8 million for Q4 2025.

• In Q4 2025, Accounts Payables rose 6.03% year-over-year to $148.8 million; the TTM figure through Dec 2025 stood at $148.8 million (up 6.03% YoY), while the FY2025 annual figure was $148.8 million, up 6.03% from the prior year.
• Accounts Payables was $148.8 million for Q4 2025 at Charles River Laboratories International, down from $169.6 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $226.0 million in Q1 2022 to a low of $110.9 million in Q2 2021.
• Historically, Accounts Payables has averaged $155.4 million across 5 years, with a median of $143.1 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Accounts Payables jumped 90.56% in 2022, then tumbled 46.9% in 2023.
• A 5-year view of Accounts Payables shows it stood at $198.1 million in 2021, then grew by 3.93% to $205.9 million in 2022, then dropped by 17.96% to $168.9 million in 2023, then dropped by 16.93% to $140.3 million in 2024, then climbed by 6.03% to $148.8 million in 2025.
• The last three Accounts Payables figures came in at $148.8 million (Q4 2025), $169.6 million (Q3 2025), and $145.8 million (Q2 2025), per Business Quant data.